Early research (Phase 1)Ended earlyNCT02437916What this trial is testingSafety Study of AMG 228 to Treat Solid TumorsWho this might be right forAdvanced MalignancyAdvanced Solid TumorsCancer+8 more Amgen 30
Testing effectiveness (Phase 2)Study completedNCT00063895What this trial is testingErlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT05858736What this trial is testingSafety, PK and Efficacy of AI-061 in Advanced Solid TumorsWho this might be right forMelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more OncoC4, Inc. 18
Testing effectiveness (Phase 2)Ended earlyNCT03729596What this trial is testingMGC018 With or Without MGA012 in Advanced Solid TumorsWho this might be right forSquamous Cell Carcinoma of Head and NeckTriple Negative Breast CancerMelanoma+3 more MacroGenics 143
Early research (Phase 1)Study completedNCT03894618What this trial is testingSL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasWho this might be right forSquamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more Shattuck Labs, Inc. 49
Early research (Phase 1)Ended earlyNCT02365662What this trial is testingA Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorWho this might be right forHead and Neck Squamous Cell CarcinomaNon-small Cell Lung CancerTriple Negative Breast Cancer+2 more AbbVie 46
Testing effectiveness (Phase 2)Looking for participantsNCT06943521What this trial is testingMT-4561 in Patients With Various Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more Tanabe Pharma America, Inc. 27
Early research (Phase 1)Looking for participantsNCT06561685What this trial is testingLY4050784 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid TumorNon-small Cell Lung Cancer+1 more Eli Lilly and Company 340
Testing effectiveness (Phase 2)Study completedNCT03997968What this trial is testingCYT-0851 in B-Cell Malignancies and Advanced Solid TumorsWho this might be right forMalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more Cyteir Therapeutics, Inc. 169
Testing effectiveness (Phase 2)Ended earlyNCT05180474What this trial is testingGEN1047 for Solid Tumors - First in Human (FIH) TrialWho this might be right forBreast Cancer, Breast NeoplasmsEndometrial Cancer, Endometrial NeoplasmOvarian Cancer, Ovarian Neoplasms+1 more Genmab 179
Testing effectiveness (Phase 2)Ended earlyNCT04442126What this trial is testingNM21-1480 in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorNon-small Cell Lung CancerColorectal Cancer+6 more Numab Therapeutics AG 52
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT04389632What this trial is testingSigvotatug Vedotin in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more Seagen, a wholly owned subsidiary of Pfizer 1,006
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Active Not RecruitingNCT04007744What this trial is testingSonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more Mayo Clinic 36
Early research (Phase 1)Looking for participantsNCT07085091What this trial is testingA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more ALX Oncology Inc. 170
Not applicableApproved For MarketingNCT06132191What this trial is testingExpanded Access Use of Cemiplimab in Patients With Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Basal Cell Carcinoma (BCC)Cutaneous Squamous Cell Carcinoma (CSCC) Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Looking for participantsNCT03556228What this trial is testingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaWho this might be right forHead and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more VM Oncology, LLC 242
Early research (Phase 1)Active Not RecruitingNCT05783622What this trial is testingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forNon-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more Janux Therapeutics 130